TRISCEND II Pivotal Trial

Clinical trial NCT04482062 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04482062
Sponsor: Edwards Lifesciences
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Tricuspid Valve Regurgitation Tricuspid Valve Insufficiency Tricuspid Valve Disease Heart Valve Diseases Cardiovascular Diseases Heart Failure

Start date: 2021-04-09
Primary completion: 2025-12-05
Enrollment: 864

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.